AAVZYME Trademark

Trademark Overview


On Tuesday, October 29, 2019, a trademark application was filed for AAVZYME with the United States Patent and Trademark Office. The USPTO has given the AAVZYME trademark a serial number of 88671830. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 18, 2023. This trademark is owned by AAV Gene Therapeutics, Inc.. The AAVZYME trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Gene therapy products, namely, genetically engineered viral vectors for gene delivery or protein expression from the gene; pharmaceutical preparations for treating genetic disorders; viral medicines for the treatment of genetic disorders; gene therapy medicines for the treatment of genetic disorders; gene therapy products, namely, therapeutics for the treatment of human disease, in particular, for genetic disorders; gene therapy delivery agents, namely, viral vectors for gene delivery or protein expression from the gene

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Conducting early evaluations in the field of new pharmaceutical and biopharmaceutical products; Development of pharmaceutical preparations and medicines; research and development of gene therapies
aavzyme

General Information


Serial Number88671830
Word MarkAAVZYME
Filing DateTuesday, October 29, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 24, 2020

Trademark Statements


Goods and ServicesGene therapy products, namely, genetically engineered viral vectors for gene delivery or protein expression from the gene; pharmaceutical preparations for treating genetic disorders; viral medicines for the treatment of genetic disorders; gene therapy medicines for the treatment of genetic disorders; gene therapy products, namely, therapeutics for the treatment of human disease, in particular, for genetic disorders; gene therapy delivery agents, namely, viral vectors for gene delivery or protein expression from the gene
Goods and ServicesTesting, inspection, research, or development of pharmaceutical preparations for gene therapy; Conducting early evaluations in the field of new pharmaceutical and biopharmaceutical products; Development of pharmaceutical preparations and medicines; research and development of gene therapies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 1, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 1, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAAV Gene Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBeverly, MA 01915

Party NameAAV Gene Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBeverly, MA 01915

Trademark Events


Event DateEvent Description
Monday, December 18, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 18, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, May 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 11, 2023SOU EXTENSION 5 GRANTED
Monday, May 8, 2023SOU EXTENSION 5 FILED
Thursday, May 11, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 8, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 7, 2022SOU EXTENSION 4 GRANTED
Monday, November 7, 2022SOU EXTENSION 4 FILED
Monday, November 7, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, May 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 9, 2022SOU EXTENSION 3 GRANTED
Monday, May 9, 2022SOU EXTENSION 3 FILED
Monday, May 9, 2022SOU TEAS EXTENSION RECEIVED
Friday, November 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 10, 2021SOU EXTENSION 2 GRANTED
Wednesday, November 10, 2021SOU EXTENSION 2 FILED
Wednesday, November 10, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, May 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 10, 2021SOU EXTENSION 1 GRANTED
Monday, May 10, 2021SOU EXTENSION 1 FILED
Monday, May 10, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 10, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 1, 2020EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, April 22, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, March 24, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 24, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 4, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 18, 2020ASSIGNED TO LIE
Tuesday, February 11, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 11, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, February 11, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 11, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, February 11, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 4, 2020ASSIGNED TO EXAMINER
Friday, November 1, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 1, 2019NEW APPLICATION ENTERED